Australia is experience potentially transformative treatment for excess weight: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – demonstrates remarkable efficacy in clinical research, suggesting meaningful decreases in body fat. While approval is pending with the Therapeutic Goods Administration (TGA), a number of indi… Read More